Efgartigimod as adjunctive therapy for immunotherapy-dependent autoimmune diencephalitis

Chang Li, Xiang Yin, Menghan Jia, Jie Shao, Li Cui

Open source

DOI
10.1097/md.0000000000050637
Published
2026-09-11
Container
Medicine
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/md.0000000000050637,
  title = {Efgartigimod as adjunctive therapy for immunotherapy-dependent autoimmune diencephalitis},
  author = {Chang Li and Xiang Yin and Menghan Jia and Jie Shao and Li Cui},
  year = {2026},
  journal = {Medicine},
  doi = {10.1097/md.0000000000050637},
  url = {https://doi.org/10.1097/md.0000000000050637}
}

RIS

TY  - JOUR
TI  - Efgartigimod as adjunctive therapy for immunotherapy-dependent autoimmune diencephalitis
AU  - Chang Li
AU  - Xiang Yin
AU  - Menghan Jia
AU  - Jie Shao
AU  - Li Cui
PY  - 2026
JO  - Medicine
DO  - 10.1097/md.0000000000050637
UR  - https://doi.org/10.1097/md.0000000000050637
ER  - 

APA

Li, C., Yin, X., Jia, M., Shao, J., & Cui, L. (2026). Efgartigimod as adjunctive therapy for immunotherapy-dependent autoimmune diencephalitis. Medicine. https://doi.org/10.1097/md.0000000000050637

Source records